Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler. Bolaget får nu in Industrifonden som ny storägare.
2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.
Although the field is now half a century old, biocatalysts are not yet the default choice for chemical process designers. EnginZyme is a biotechnology company that specializes in biocatalysis. Search Crunchbase. Advanced Search. Try Pro free Solutions. Products. Resources.
The Company invests in business, consumer technology and life Dec 17, 2020 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden. EnginZyme Extends Series A Feb 11, 2021 EnginZyme (the three founders Robin Chatterjee, Karim Engelmark where SEB Greentech and Industrifonden is participating along with Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande Karim Engelmark Cassimjee, som har grundat Enginzyme tillsammans med Robin Bolaget får nu in Industrifonden som ny storägare. Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar EnginZyme AB - Paving the way to cell free synthetic biology, the next Director of Enzyme Engineering at EnginZyme Deep Tech VC at Industrifonden. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the I höstas var Enginzyme med på Ny Tekniks 33-listan som ett av Sveriges bästa unga teknikbolag.
EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach
Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme. 80, Mosaic Industrifonden.
"EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency," said Patrik Sobocki, Investment Manager at Industrifonden.
Save . Summary Financials People Technology Signals & News. 2021-02-11 “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme extends Series A to EUR 11 million. February 17, 2021. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, Athera (company).
Nu tar bolaget in 111 miljoner bland annat från Industrifonden. Med nya miljoner i kassan ska kemiteknikbolaget Enginzyme ta sig från labbet till marknaden.
Leukoplaki
EnginZyme’s cell-free bio-manufacturing platform marries the efficiency of the chemical industry with the power and diversity of biology, establishing a foundation for the future chemical industry. The company is headquartered in Stockholm, Sweden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler.
EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical
Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden.
Origami bookmark instructions
Patrick Sobocki. Director at Industrifonden Karim Cassimjee. CEO and co- founder at EnginZyme Deep Tech Track by Industrifonden & EQT Ventures.
Synthetic Biology – enabling the nascent bioeconomy. January 21, 2021 .
Svakom promo code
EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical
Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders.